Tysabri every eight weeks may cut PML risk
Tysabri every eight weeks may cut PML risk
Preliminary findings from an ongoing study of multiple sclerosis patients suggest the dosing interval for Tysabri can be as much as doubled from the label-recommended standard without sacrificing efficacy, and with potentially less risk of progressive multifocal leukoencephalopathy (PML) -- even among patients with more than average PML risk, researchers claim... Read More - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2553 Views
-
Last post by NHE
-
- 0 Replies
- 326 Views
-
Last post by NHE
-
- 6 Replies
- 7523 Views
-
Last post by ElliotB
-
- 0 Replies
- 3789 Views
-
Last post by NHE
-
- 0 Replies
- 1422 Views
-
Last post by NHE
-
- 0 Replies
- 294 Views
-
Last post by NHE
-
- 0 Replies
- 3483 Views
-
Last post by NHE
-
- 11 Replies
- 3532 Views
-
Last post by NHE
-
- 1 Replies
- 1156 Views
-
Last post by NHE